IL4 and neoplasm: Recent studies have also shown that Wnt ligands produced by cancer cells use β-catenin signaling to stimulate immunosuppressive TAMs that support tumor growth and metastasis, and to upregulate the production of anti-inflammatory IL-4 and TGFβ (80).